Panve health - Company finances
|
EUR
|
2024
From: 2024-05-03
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 1,731 | 35,459 |
| Profit before tax | -512 | 15,204 |
| Net profit | -512 | 14,322 |
| Equity | -8 | 14,314 |
| Liabilities | 4,336 | 24,885 |
| Non-current assets | 0 | 757 |
| Current assets | 4,328 | 38,442 |
| Total assets | 4,328 | 39,199 |
|
Financial indicators
|
||
| Revenue change y/y | - | +1948.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -11.8% | 36.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 100.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -29.6% | 40.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -29.6% | 42.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 1.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Panve health - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-03 | 2026-05-31 | 32.12 |
| 2026-04-01 | 2026-04-30 | 24.09 |
| 2026-03-03 | 2026-03-31 | 16.06 |
| 2026-02-03 | 2026-02-28 | 8.03 |
| 2025-09-02 | 2025-09-30 | 144.90 |
| 2025-08-01 | 2025-09-01 | 72.45 |
| 2025-07-01 | 2025-07-31 | 217.35 |
| 2025-06-03 | 2025-06-30 | 144.90 |
| 2025-05-04 | 2025-06-02 | 72.45 |
| 2025-04-01 | 2025-04-30 | 217.35 |
| 2025-03-04 | 2025-03-31 | 144.90 |
| 2025-03-03 | 2025-03-03 | 72.45 |
| 2025-03-01 | 2025-03-02 | 144.90 |
| 2025-02-01 | 2025-02-28 | 72.45 |
| 2025-01-02 | 2025-01-31 | 258.00 |
| 2024-12-03 | 2024-12-31 | 193.50 |
| 2024-11-04 | 2024-12-02 | 129.00 |
| 2024-10-01 | 2024-11-03 | 64.50 |
Panve health - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-30 | 2026-08-31 | 46.51 |
| 2026-08-28 | 2026-08-29 | 46.5 |
| 2026-06-19 | 2026-07-26 | 0.48 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Panve health, MB (code 306742342) is a Lithuanian small partnership engaged in other non-specialised retail sale. In the latest financial year, 2025, the company generated EUR 35.5K in revenue and reported net profit of EUR 14.3K, compared with a net loss of EUR 512 in 2024. This indicates a clear turnaround in profitability over the year. The 2025 profit margin was 40.4%, reflecting materially improved operating performance. Revenue also increased sharply from EUR 1.7K in 2024 to EUR 35.5K in 2025, showing strong business expansion from a very small base. At the end of 2025, total assets stood at EUR 39.2K, supported mainly by short-term assets of EUR 38.4K and long-term assets of EUR 757. Equity was EUR 14.3K, while liabilities amounted to EUR 24.9K. Key ratios for 2025 show return on equity of 100.1%, return on assets of 36.5%, debt-to-equity of 1.74, and asset turnover of 0.90x. The balance sheet strengthened significantly year on year, although liabilities remained above equity.